Lilly announces retirement of Marschall S. Runge from its Board of Directors

INDIANAPOLIS, Aug. 16, 2024 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that Marschall S. Runge, M.D., Ph.D. is retiring from his role as an independent director of Lilly’s board of directors effective Aug. 31, 2024. Dr. Runge has served on Lilly’s board since 2013,…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.